QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national procedures

Ibuprofen product-specific bioequivalence guidance

Dolutegravir product-specific bioequivalence guidance

Levothyroxine product-specific bioequivalence guidance

Medicinal Product master data for better regulation and better health - Network Data Steering Group (NDSG) recommendations for human Product Master Data implementation and data management

Annual accounts: Financial year 2024

Declaration on the qualification of an enterprise as a micro, small or medium-sized enterprise (SME)

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

Transparency: exceptional measures for COVID-19 medicines

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised